MAPP BIOPHARMACEUTICAL, INC. SBIR Phase II Award,
A SBIR Phase II contract was awarded to Mapp Biopharmaceutical Inc for $2,815,180.0 USD from the U.S. Department of Health & Human Services.
Is a
Award Amount (USD)
2,815,180
SBIR/STTR Award Recipient
Contract Number (US Government)
2R44AG025641-03
Award Phase
Phase II
Award Type
SBIR
Official Website
Find more entities like MAPP BIOPHARMACEUTICAL, INC. SBIR Phase II Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.